.png)
The Scalpels & Spreadsheets Podcast
The Scalpels & Spreadsheets Podcast explores the future of healthcare through conversations with the builders, investors, operators, and clinicians shaping the industry.
Scalpels & Spreadsheets brings together the global healthcare community through media, curated events, and meaningful connections. The podcast extends that mission beyond the room, amplifying the people and ideas driving healthcare forward when we’re not facilitating them in person.
Episodes
39 episodes
#38 Population Health: Chronic Care Coordination to AI-Driven Outcomes
Population health has always depended on data. The challenge now is determining where AI creates the most value and where human judgment still matters.Rich Hofbauer (CEO, Alopex), Stephen Kelly (...
.png)
#37 The Great Lab Exit: From Academia to Funded Ventures.
Great science rarely becomes a great company on its own. The challenge is turning research into something customers, investors, and partners believe in.Aykut Aksit (Co-Founder & CEO, Haysta...
.png)
#36 Part 2: Health Systems, Clinicians, & the Consumer Health Era
Patients are no longer walking into the clinic with just symptoms. They're arriving with wearable data, lab results, GLP-1 prescriptions, peptide protocols, and AI-generated health advice already shaping how they think about their care. What do...
.png)
#35 Part 1: Health Systems, Clinicians, & the Consumer Health Era
Patients are no longer starting their healthcare journey inside the health system. Increasingly, it begins with a wearable, a direct-to-consumer service, or an AI-powered tool long before a clinician is involved.Dr. Devin Mann (Director...
.png)
#34 EKGs as a Biomarker. Moin Hussaini. Ambreen Mohamed.
The ECG has been a cornerstone of cardiology for more than a century. AI is revealing that it may contain far more information than clinicians ever realized.Moin Hussaini (Head of Product, A...
.png)
#33 Ugly Talk: The GTM Founder Playbook. Kanika Agarwal. Osama Usmani.
Finding product-market fit in healthcare is a balancing act between customer needs, pricing, distribution, ROI, and countless other variables. Those tradeoffs look different depending on the market you're serving and the stage of the company yo...
.png)
#32 The Investor’s Playbook: Inside the Healthcare Fundraising Process. Sean Day. Daniella Cohen. Ruth Segall. Stephanie Mouchbahani-Constance.
How do healthcare investors evaluate companies at different stages of growth?In this panel, Daniella Cohen (Principal at 2048 Ventures), Ruth Segall (Associate at ...
.png)
#31 She Speaks Health: What Great Operators Do. Melody Yao. Amanda Kichline. France Ovalle.
Building a healthcare startup is one challenge. Building the systems that allow it to scale is another.Melody Yao (Strategy & Operations, Ambience Healthcare) and Amanda Kichline (Fo...
.png)
#30 How Takeda Is Reinventing Pharma with AI. Gabriele Ricci.
AI is reshaping every stage of the pharmaceutical value chain, from discovering new medicines to delivering better outcomes for patients. The companies that lead won't simply adopt better models. They'll rethink how they operate.Gabriel...
.png)
#29 Sick Care is Dead. What Comes Next?
The doctor's office is no longer the default entry point into healthcare. So what comes next?Royan Kamyar, MD (Founder & CEO, Owaves), Dr. Sohaib Imtiaz, MD, MPH (Chief Medical Officer,
.png)
#28 Health AI: From Research to Production. Nyamitse-Calvin Mahinda. Timothy Martens. Kerry Weinberg. Vitalay Fomin.
Most healthcare AI conversations focus on what was built. This one focused on what it actually takes to get it into the hands of people who need it.Kerry Weinberg (Founder & CEO of PhenoML), Vitalay...
.png)
#27 Deploying AI in Healthcare’s Most Complex Systems. Martin Seneviratne. Brittany Sigler.
What does it take to move healthcare AI from theory to operation?Martin Seneviratne, Co-CEO of R37 at R1, joins Brittany Sigler, Founder of Bright Signal Consulting, for a fireside conversation exp...
.png)
#26 Off the Record: The Human Layer of AI Drug Discovery
Building one of Canada's leading AI-driven genetic medicines platform companies didn't happen without hard decisions, failed bets, and the willingness to pivot.Tom Masterson, Chief Operating Officer at
.png)
#25 Closing the Deal: Structuring Contracts that Scale. Bettina Xue Griffen. Meagan Tanguilig.
Bettina Xue Griffen, a Commercial Lawyer at Fasken, joins for a fireside chat on the legal and commercial realities of selling into healthcare. Drawing from her experience helping startups and scaleups navigate enterprise contracts, Bettina sha...
.png)
#24 How Healthtech Teams are Integrating AI into Live Products. Bruno Ferrari. Otto Sipe. Vikas Sharma.
AI has become the biggest conversation in healthcare, but what does it mean if you already have a product in the market? Do you pivot to compete with AI native companies or stay steady? On the other side, will the speed and adaptability of AI-f...
.png)
#23 How AI Can Transform Healthcare Systems. Ricardo Baptista Leite. Vijesh Vijayan
CEO of HealthAI, Dr. Ricardo Baptista Leite joins the S&S Podcast at Web Summit for a Special Edition to discuss the transformative role of AI in healthcare. Medical Doctor and former lawmaker, Dr. Ricardo Leite is the Founder and President...
.png)
#22 Going All In on Digital Health: A Founder-Investor Journey. Nadav Shimoni & Moran Snir.
Nadav Shimoni, a physician turned investor is the Managing Partner at A-Squared Ventures, an early-stage digital health fund spanning Tel Aviv & NYC. He joins Moran Snir, a serial genomics entrepreneur and currently the co-founder & CEO...
.png)
#21 Democratizing Drug Prices using AI. Miriam Paramore. Vijesh Vijayan.
Miriam Paramore, Founder & CEO of RxUtility sits down with us to chat about why drug prices should be more affordable and why she is building in this space.In this conversation, Miriam covers the evolution of healthcare technology a...
.png)
#20 Fundraising in Health Tech: Seed vs Series A vs Beyond. Katheleen Eva. Stephanie Mouchbahani-Constance
Kathleen Eva, Investor at StandUp Ventures, is joined by Stephanie Mouchbahani-Constance, Principal at KLI Capital, for a live conversation on what founders need to know about fundraising in 2026.Together, they unpack shifting investor e...
.png)
#19 The Power of Partnerships for Drug Discovery. Anmol Nagpal.
Anmol Nagpal is the founder and CEO of Nospharma, a pre-clinical therapeutics company developing innovative treatmen...
.png)
#18 Breaking Through: Getting Products Into the Health System. Shafiq Vallani.
Shafiq Vallani (Head of Canada at Redesign Health) is a seasoned venture capital investor, now supporting the next generation of healthcare ventures in Canada. He has built a reputation for identifying high-potential startups and driving them t...
.png)
#17 How Innovators can navigate the private healthcare ecosystem. Tim Clarke.
Tim Clarke (CEO of tc Health Consulting) is a former Chief Innovation Officer at Aon Hewitt for Health & Benefits. He now draws from 20 years of experience to support local and international healthcare ventures looking to grow revenue strea...
.png)
#16 The API Revolution in Healthcare. Kristen Valdes. Vijesh Vijayan.
Kristen Valdes, Founder & CEO of b.well Connected Health shares her extensive journey in healthcare, highlighting her experiences from being a healthcare executive to founding b.well and more. She shares pivotal moments in healthcare innova...
#15 Embedding Intelligence: How AI is Redefining Home and Community Care. Naomi Goldapple. Stephanie Mouchbahani-Constance.
As part of the Montreal Healthtech Social held on November 27, we were joined by Naomi Goldapple, the Senior Vice President of Data and Intelligence at AlayaCare, where she leads AI and data strategy to transform home healthcare.
.png)
#14 How AI Cuts Trial Costs & Boosts Drug ROI. Vinodh Balaraman.
As part of the NYC Healthtech Social held on October 27, Vinodh Balaraman, a serial entrepreneur and Founder of Kolate AI, joined us for a fireside chat on how AI can improve clinical development and drug decision-making. Kolate AI is a precisi...
.png)